Mirabegron for frequent ventricular tachycardia
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether a drug called mirabegron (usually for overactive bladder) can reduce very frequent episodes of a heart rhythm problem called ventricular tachycardia (VT). If you have an implantable cardioverter-defibrillator (ICD) and still get at least 2 VT episodes a month despite standard heart medicines, this might be a new option to control them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have an ICD (implantable cardioverter-defibrillator) and have had more than 2 episodes of ventricular tachycardia (VT) per month, on average, in the past 2 months.
- You are still getting VT despite being on standard heart medicines.
- You are not pacemaker-dependent.
- You are not pregnant or breastfeeding.
- You are not taking any of these medicines: codeine, oxycodone, thioridazine, flecainide, propafenone, or digoxin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two catheter-based procedures to treat ventricular tachycardia (VT), a fast, dangerous heart rhythm. It looks to see which approach works better at reducing repeat VT events in people with weakened heart pumping.
This trial tests a non-invasive nerve stimulation treatment (using a small device on the ear) to reduce dangerous heart rhythm problems. It is for people with frequent premature heartbeats (PVCs) or with an implanted defibrillator who have had repeated episodes of a fast heart rhythm (VT).
This trial tests a new treatment that uses short bursts of energy to target and destroy the heart tissue causing a fast, potentially serious heart rhythm problem (ventricular tachycardia). It's designed for people who already have an ICD and haven't gotten enough help from medications.
This trial studies a special “needle” ablation method (with saline) to treat a dangerous, repeat heart rhythm problem called monomorphic ventricular tachycardia (VT). It’s for adults whose VT keeps coming back despite prior treatments and who may not benefit from another standard ablation.
This trial tests a new catheter-based procedure to treat life-threatening irregular heartbeats (ventricular tachycardia) that keep coming back despite medication. If you've had a heart attack and your implanted defibrillator hasn't fully controlled these arrhythmias, this procedure might help prevent future episodes.
This trial tests a new way of mapping the heart's electrical activity during a procedure called catheter ablation, which aims to treat a fast heart rhythm problem called ventricular tachycardia (VT). The hope is that this personalised approach will make the procedure more effective in stopping these abnormal rhythms.
Hear when a new Ventricular Arrhythmias and Cardiac Arrest trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.